Siemens Healthineers AG

Company Snapshot

Founded: 2015
Entity Type: Public
Employees: 72,000
Region: U.S.
Revenue: $24,245.3 Millions
Revenue Year: 2024
Segment: Varian
Headquarter: Forchheim, Germany
Key Geographics: Asia-Pacific, Europe, C.I.S., Americas, Middle East (EMEA)

Company Overview

Siemens Healthineers develops and manufactures diagnostic and therapeutic products to healthcare providers in more than 180 countries. It also provides clinical consulting services. As of Sept. 30, 2023, the Siemens Group held just over 75% of the shares in Siemens Healthineers AG.

Its business operations are divided into four segments: Imaging, Diagnostics, Varian and Advanced Therapies. The Cancer Therapy business (imaging for radiation therapy) was assigned to the Varian segment on Oct. 1, 2022. Siemens acquired Varian Medical Systems Inc. in 2021. Varian’s Radiation Oncology Solutions business serves the end-to-end needs of customers with integrated equipment and digital solutions.

The portfolio of its Diagnostics segment comprises in-vitro diagnostic products and services that it offers to healthcare providers in the fields of laboratory diagnostics and point-of-care diagnostics.

Siemens Healthineers AG In Reports

AI in Neurology: Global Markets

According to our research analyst the AI in Neurology Markets includes global revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the forecast period 2026 through 2030.

Biological and Medical Imaging Reagents: Global Markets

BCC Research Report: Dive into biological and medical imaging reagents market revenues are broken down by region and have been estimated for the five-year period from 2024 through 2029.

Molecular Diagnostics: Technologies and Global Markets

According to our research analyst the molecular diagnostics market includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.

Company's Business Segments

  • Imaging : Devices for magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound.
  • Diagnostics : Testing disciplines, including immunochemistry, hematology, coagulation, urinalysis, blood gas analysis, and molecular tests.
  • Varian : Multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments, integrated equipment and digital solutions.
  • Advanced Therapies : Angiography systems and mobile C-arms.

Applications/End User Industries

  • Theranostics
  • Cardiology
  • Neurology
  • Oncology
  • Surgery
  • Interventional Radiology
  • Hepatology
  • Critical Care
  • Covid-19
  • Women's Health
  • Medical Devices
  • Healthcare
  • Assays by diseases & conditions
AI: Your Say